Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Newborn screening for spinal muscular atrophy in Japan: One year of experience.
Sawada T, Kido J, Sugawara K, Yoshida S, Ozasa S, Nomura K, Okada K, Fujiyama N, Nakamura K. Sawada T, et al. Among authors: fujiyama n. Mol Genet Metab Rep. 2022 Aug 2;32:100908. doi: 10.1016/j.ymgmr.2022.100908. eCollection 2022 Sep. Mol Genet Metab Rep. 2022. PMID: 35942129 Free PMC article.
Correction to: Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
Fujiyama N, Tasaki M, Harada H, Tsutahara K, Matsumoto A, Kamijo Y, Toyoda M, Iwami D, Inui M, Shirakawa H, Sugimura J, Saito M, Hotta K, Okumi M, Saito K, Watarai Y, Hidaka Y, Ohtani K, Inoue N, Wakamiya N, Habuchi T, Satoh S; Japanese Post-kidney Transplant TMA Support Team. Fujiyama N, et al. Clin Exp Nephrol. 2023 Dec;27(12):1021-1022. doi: 10.1007/s10157-023-02409-y. Clin Exp Nephrol. 2023. PMID: 37864681 No abstract available.
Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
Fujiyama N, Tasaki M, Harada H, Tsutahara K, Matsumoto A, Kamijo Y, Toyoda M, Iwami D, Inui M, Shirakawa H, Sugimura J, Saito M, Hotta K, Okumi M, Saito K, Watarai Y, Hidaka Y, Ohtani K, Inoue N, Wakamiya N, Habuchi T, Satoh S; Japanese Post-kidney Transplant TMA Support Team. Fujiyama N, et al. Clin Exp Nephrol. 2023 Dec;27(12):1010-1020. doi: 10.1007/s10157-023-02391-5. Epub 2023 Aug 27. Clin Exp Nephrol. 2023. PMID: 37634218
Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version).
Harada H, Fukuzawa N, Abe T, Imamura R, Masaki N, Fujiyama N, Sato S, Hatakeyama S, Nishimura K, Kishikawa H, Iwami D, Hotta K, Miura M, Ide K, Nakamura M, Kosoku A, Uchida J, Murakami T, Tsuji T. Harada H, et al. Among authors: fujiyama n. BMC Nephrol. 2023 Jun 6;24(1):158. doi: 10.1186/s12882-023-03189-z. BMC Nephrol. 2023. PMID: 37280521 Free PMC article.
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
Takahashi S, Narita S, Fujiyama N, Hatakeyama S, Kobayashi T, Kato R, Naito S, Sakatani T, Kashima S, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Obara W, Tsuchiya N, Ohyama C, Ogawa O, Habuchi T. Takahashi S, et al. Among authors: fujiyama n. Cancer Sci. 2022 Dec;113(12):4059-4069. doi: 10.1111/cas.15488. Epub 2022 Sep 24. Cancer Sci. 2022. PMID: 35848083 Free PMC article.
Advanced Tertiary Lymphoid Tissues in Protocol Biopsies are Associated with Progressive Graft Dysfunction in Kidney Transplant Recipients.
Lee YH, Sato Y, Saito M, Fukuma S, Saito M, Yamamoto S, Komatsuda A, Fujiyama N, Satoh S, Lee SH, Boor P, Habuchi T, Floege J, Yanagita M. Lee YH, et al. Among authors: fujiyama n. J Am Soc Nephrol. 2022 Jan;33(1):186-200. doi: 10.1681/ASN.2021050715. Epub 2021 Nov 1. J Am Soc Nephrol. 2022. PMID: 34725107 Free PMC article.
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Kobayashi M, Fujiyama N, Tanegashima T, Narita S, Yamamoto Y, Fujimoto N, Ueda S, Takeuchi A, Numakura K, Habuchi T, Matsuyama H, Eto M, Shiota M. Kobayashi M, et al. Among authors: fujiyama n. Cancer Immunol Immunother. 2022 Mar;71(3):727-736. doi: 10.1007/s00262-021-03032-0. Epub 2021 Aug 11. Cancer Immunol Immunother. 2022. PMID: 34379177 Free PMC article.
43 results